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ABSTRACT 
 
A container was developed for the transport and conservation of 
immunological products under low temperatures of between 2 and 8 º C, 
within a time span of 8 hours. The container is practical, simple and user-
friendly, and can be used in places without electric power, and all these 
advantages are added of low operational costs. 
The container proposed aims at meeeting the demand of the Programa 
Nacional de Imunizações (PNI- the National Immunization Program), 
through Cold Chain, which sets the standards for all the procedures 
concerning conservation, handling, distribution and transport of the vaccine 
from the laboratory that produces it to the moment of inoculation. 
Innitially, the container was specifically developed for Vaccine for Inactive 
Influenza Virus against flu, which, according to a survey conducted with 
laboratories, is the most widely consumed, and  whose conservation time 
span is also applicable to other immunobiologicals 
After the design and construction of the prototype, the container was 
exhaustively tested under different weather conditions. The results of the 
experiment are being exposed and discussed in this paper and the prototype 
lived up to the expectations of the reserachers in terms of the time spans and 
temperatures foreseen for the conservation of the vaccine selected. 
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NOMENCLATURE 
 
T Temperature of the vaccine at a certain 
moment [º C]. 
T∞        Room temperature [ º C ]. 
TV           Temperature of the vaccine at the beginning 
of the monitoring process [º C]. 
θ             Represents temperature. 
t Period of time of conservation of the 
vaccine at the interval of  2 a 8 º C [h] . 
t *           Desirable time of  8 hours. 
δ             Represents time.  
θ máx       Non-dimensional of maximum temperatu- 
re of vaccine.  
θ min       Non-dimensional of minimum temperature 
of vaccine. 
 
INTRODUCTION 
 
From the early days of humanity 
morbimortality rates (mortality caused by disease) 
has been very high, thus there emerged with the 
evolution of the biological sciences a pressing 
need for scientific research geared to the 
development of methods and parameters to reduce 
this rate. 
This research effort led to the creation of 
vaccines and immunobiologicals, defined as 
microorganisms used to provoke active immunity 
states against certain infectious diseases. The 
vaccines are made of attenuated viruses, 
producing antibodies and antitoxins. In order to 
ensure that immunobiologicals preserve their 
initial characteristics, it is vital that they are 
refrigerated at temperatures of between 2 and 8 º 
C, which can preserve their immunobiological 
capacity. The immunobiologicals are thermolabil 
and as such they will deteriorate after a certain 
time of exposure to temperatures inadequate to 
their preservation, since heat will speed the 
process of inactivation of the immunogenic 
components. The Cold Chain Manual, written by 
Funasa (2001), includes the norms and procedures 
for all the processes involved in the storage, 
conservation, handling, distribution and 
transportation of immunobiologicals of PNI 
(Programa Nacional de Imunizações – The 
National Immunization Program). The procedures 
described in this manual dictate that the 
immunobiologicals must be placed and 
transported in polystyrene or polythene boxes, 
previously encircled by recyclable ice spools, and 
that during vaccination campaigns ice cubes of 
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scraped ice must be used inside plastic bags. This 
is a completely unacceptable practice, once the 
plastic bags with ice, due to their irregular shape, 
make it difficult for the immunobiologicals to be 
duly ensconced, and the empty spots inside these 
bags compromise thermal insulation, thus 
jeopardizing temperature maintenance. On top of 
all that, when the professional opens the box to 
handle the vaccine, he or she will be exposing all 
the other vaccines to the heat that comes from 
outside, and which will speed the heating process. 
A number of studies have been carried out on 
the conservation of immunobiologicals. Sbeghen 
(1998), concluded that the system used for the 
conservation of the vaccines is vital if the quality of 
the vaccines is to be guaranteed; and the main cause 
for the loss of vaccines in the public vaccination 
programs in the US is the inadequacy of Cold 
Chain. 
Rizzo et al. (1990) observed in an experiment 
that photosensibility and thermostability are 
determining factors in the fall of potency when the 
vaccines are exposed to the incidence of light. 
Exposure of the vaccines to heat leads to low 
stability and reduction of homogeneity. 
Malinverni (2003), concluded that any breach 
in this Cold Chain may cause the vaccine to lose its 
immunization property, since there is a direct 
correlation between the effectiveness of the 
vaccines and the maintenance of the cold chain at 
every stage, that is, form their production to their 
storage, to transport and handling.  
The mode of conservation of biological 
products, according to Hoffmeister (2001), must be 
as adequate as possible, because the temperatures 
outside the conservation band will affect the 
effectiveness of the vaccine and cause localized 
reactions in the patients. 
After experimental tests, Albas et al. (2001) 
published that the anti-rabies vaccine produced in 
the brains of newly-born mice practically lost its 
capacity to induce neutralizing anti-bodies when 
frozen. Such conditions have rendered the vaccine 
useless for pigs and most probably for human 
beings. 
The purpose of the project was to research 
into the reliability of the current procedures, 
seeking the likely optimization of the process and 
securing the maintenance of the quality of the 
vaccines as well as the enhancement of the 
process as a whole by implementing vaccination 
campaigns.  
The container was developed, built and tested 
in order to assist the Cold Chain professionals, by 
guaranteeing the quality and the effectiveness of 
the immunobiologicals, rendering handling easier, 
promoting functionality, opperationality and low 
implantation costs. 
  
 
METODOLOGY 
 
Today, the Cold Chain is used in the transport 
and conservation of conventional vaccine boxes 
made of polystyrene or polyurethane, surrounded 
by recyclable ice spools and filled with the 
packaging containing the vaccines. 
Taking as a basis the Cold Chain Manual, a 
polystyrene container was designed for the 
maintenance of the temperature inside it, at the 
band needed for the effective conservation of the 
vaccines, and keep the thermo condition of each 
vaccine unaltered while they are being transported 
and while the vaccines are being inoculated. 
So that the inner space is better used, holding 
the largest possible number of units, the individual 
thermal insulation of each corner of the container 
was carefully studied as well as the improvement of 
the inner layout of the box.   
The inner space of the container has two 
polystyrene grids for the vertical storage of the 
vaccines, making it possible for individual caps to 
be used, so that one vaccine can be handled without 
altering the temperature of the others. It also has 
four thermal ice walls that work as a barriers, 
preventing heat from the outside from entering the 
interior of the box.  
 
 DESCRIPTION OF THE CONTAINER 
 
The container developed is of a rectangular 
shape, 610 mm long, 430 mm wide and 210 mm 
high, and has a capacity for 32 units. For the 
building of the prototype the material of choice was 
a P2 polystyrene plate, with a density of 220 kg/m
3
 
and 30 mm thick, according to Fig. 1. 
 
 
Figure 1. A, B, C and D position of the 
thermocouples during the tests. 
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 DESCRIPTION OF THE THERMAL WALLS 
 
The dimensions of the thermal walls are similar 
to those of the recyclable ice spools used today in 
the vaccination practices, being 510 mm long, 120 
mm high e 20 mm thick, as indicated in Fig. 1. 
 
 EXPERIMENTAL PROCEDURE 
 
The experimental tests were conducted in three 
different environments, in conditions that are the 
most usual possible in terms of real current 
practices. They are as follows: 
Test 1:non-refrigerated closed environment without 
incidence of sunlight. 
Test 2: open air in the shade. 
Test 3: open air with direct incidence of sunlight. 
 
POSITION OF THE THERMOCOUPLES  
 
Since the symmetry of the developed container 
is xy; its thermal behavior was analyzed by means 
of the study of one fourth of the system. This is the 
reason why the thermocouples were positioned as 
shown in Fig. 1. 
 
 DATA COLLECTION 
 
The data on the temperature of the system were 
collected by means of a Tpaq 100 data collection 
plate, produced by Datapaq Inc, capable of storing 
16,000 measurement values, through 8 data 
collection channels. This plate operates with 
thermopairs of the K type, have a resolution of 0.1º 
C and precision of ± 1º C. 
Table 1 – Error in the measurement of the thermocouples by taking as a basis the standard thermocouples. 
 
THERMOCOUPLES 
TEMPERATURES  °C 
POSITION A POSITON B POSITION C POSITION D 
TIME 
(min) 
STANDARD 
I IM I IM I IM I IM 
5 0.90  0.30  -0.60  0.60  -0.30  0.50  -0.40  0.40  -0.50  
10 1.70  1.20  -0.50  1.40  -0.30  1.20  -0.50  1.40  -0.30  
15 2.20  2.00  -0.20  2.20  0.00  2.10  -0.10  2.10  -0.10  
20 2.90  2.90  0.00  3.00  0.10  2.90  0.00  2.90  0.00  
25 3.60  3.70  0.10  3.90  0.30  3.80  0.20  3.90  0.30  
30 4.50  4.90  0.40  5.00  0.50  5.00  0.50  5.00  0.50  
35 5.30  5.70  0.40  5.80  0.50  5.70  0.40  5.80  0.50  
40 6.40  6.60  0.20  6.80  0.40  6.60  0.20  6.70  0.30  
45 7.20  7.50  0.30  7.60  0.40  7.60  0.40  7.60  0.40  
50 8.10  8.00  -0.10  8.00  -0.10  7.90  -0.20  8.00  -0.10  
55 9.00  8.80  -0.20  8.90  -0.10  8.90  -0.10  8.90  -0.10  
60 9.80  9.40  -0.40  9.40  -0.40  9.40  -0.40  9.40  -0.40  
65 10.40  10.20  -0.20  10.30  -0.10  10.20  -0.20  10.30  -0.10  
70 11.50  10.80  -0.70  10.90  -0.60  10.80  -0.70  10.90  -0.60  
Emax = 0.70 Emax = 0.60 Emax = 0.70 Emax = 0.60 
Emin = 0.00 Emin = 0.00 Emin = 0.00 Emin = 0.00  
Emean = 0.30 Emean = 0.30 Emean = 0.30 Emean = 0.30 
IT BEING: I = Uncertainty         IM = Mean uncertainty 
 
 
METHODOLOGY FOR THE CALIBRATION 
OF THE THERMOCOUPLES AND ERROR 
 
Once a contact digital thermocouple had been 
defined as standard, a mixture of ice and water was 
prepared, and 15 (fifteen) temperature measurement 
were taken with 04 (four) thermocouples used in 
the experiment and connected to the DATAPAQ 
data collection plate. 
Table 1 shows the error in the measurements of 
each thermocouple, by taking as a basis the 
behaviour of the thermocouple defined as being 
standard.  The variations are not very significant, 
once the temperature for the conservation of the 
vaccine may fluctuate between 2 and 8º C.     
RESULTS OBTAINED  
In the presentation of the results the 
temperature and time variables were non-
dimentionalised, having behaved in this way, as a 
whole, during the monitoring process in the Tests 1, 
2 and 3 proposed: 
θ = (T – T ∞ ) / (TV – T ∞) represents 
temperature; T∞ room temperature; T the 
temperature of the vaccine at a certain moment and 
TV  the temperature of the vaccine at the beginning 
of the monitoring process. 
δ = t / t * represents time; t represents the 
period of time of conservation of the vaccine at the 
interval of  2 to 8 º C, and t * the desirable time of 8 
hours. This non-dimensional represents the 
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parameters that indicate the performance of the 
system. 
The diagrams show the mean temperatures 
obtained from the vaccines during the monitoring 
process. This parameter satisfactorily represents the 
thermal behavior of the vaccine, the standard 
deviation being negligible and the means, modes e 
medians having practically the same values. 
 
RESULTS OF THE EXPERIMENTAL TESTS 
– TEST 1 
 
The mean temperature profile obtained is inside 
the tolerance band indicated by θ maximum        and  
θ minimum . As a result, the vaccine was conserved for 
a much longer period of time than the expected. 
The conservation time of the vaccine during the 
experiments, at the interval of 2 to 8º C, was of 
approximately 17 hours, that is, 2.125 longer than 
the desirable period of time. 
Table 2 shows the mean values of θ obtained in 
the positions A, B, C and D. 
 
Table 2 – The mean values of θ obtained in the 
positions A, B, C and D. 
TEST     1 – θ Values  
δ = t  /  t * Mean Median Mode 
Standard 
Deviation 
0,00 1,00 1,00 1,00 0,00 
0,25 1,10 1,10 1,11 0,01 
0,50 1,10 1,10 1,11 0,01 
 0,75 1,10 1,10 1,10 0,00 
1,00 1,11 1,11 1,11 0,00 
1,25 1,11 1,10 1,10 0,01 
1,50 1,11 1,11 1,11 0,00 
1,75 1,11 1,11 1,10 0,01 
2,00 1,11 1,10 1,11 0,01 
2,25 1,10 1,10 1,10 0,00 
 
In Test 1, the temperature curve remained 
unchanged for the values of θ above 1.00, leading 
to the conclusion that the temperatures of the 
vaccines stabilized at very low values, below the 
temperature at the beginning of the process, 
according to Fig. 2. 
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Figure 2. Profile of the mean temperature in the 
positions A, B, C and D – Test 1. 
Figure 3 shows the period of time the 
temperature of the vaccine was maintained as a 
result of the position of each thermopair. In position 
A, due to the vaccine’s closeness to the outer wall, 
its conservation time was shorter when compared to 
the other positions, which indicates the evaluation 
of the behavior of the container in terms of the 
conservation time obtained in position A. 
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 Figure 3. Temperature maintenance time of the 
vaccine x Position of each thermopolar inside 
the container. 
 
 RESULTS OF THE EXPERIMENTAL TESTS 
– TEST 2 
 
The majority of the vaccination practices occur 
in the open air in the shade, and the proposed 
container lived up to the expected performance; 
with a slight rise in the temperature of the 
immunibiologicals at the beginning of the process 
and after the stabilization for the values of θ close 
to 1.00. It was concluded that the temperatures of 
the vaccines remained practically the same as those 
at the beginning of the process. 
The conservation time of the vaccine at the 
interval 2 to 8 º C, obtained during the experiments 
in this test was of 17.5 hours, that is, 2.1875 times 
longer than the expected time. 
Table 3 shows the mean values of θ obtained in 
the positions A, B, C and D. 
 
Table 3 – The mean values of θ obtained in the 
positions A, B, C and D. 
TEST     2  - θ Values  
δ = t  /  t * Mean Median Mode 
Standard 
Deviation 
0,00 1,00 1,00 1,00 0,00 
0,25 1,00 1,01 0,96 0,03 
0,50 0,99 1,01 0,95 0,03 
0,75 0,99 1,02 0,96 0,03 
1,00 1,00 1,03 0,97 0,03 
1,25 1,02 1,04 0,99 0,03 
1,50 1,03 1,06 1,00 0,03 
1,75 1,04 1,06 1,00 0,03 
2,00 1,03 1,06 1,00 0,03 
2,25 1,02 1,03 1,01 0,02 
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Fig.4 indicates a very coherent temperature 
profile, the thermal behavior being that foreseen 
for the system, taking into consideration the 
environment proposed, which contributed to cause 
a slight rise in the temperature of the system as a 
whole at the beginning of the monitoring process. 
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Figure 4. Profile of the mean temperature in the 
positions A, B, C and D – Test 2. 
 
The thermopair in position A, due to its 
proximity to the environment outside, presented the 
shortest conservation periods of time of the vaccine 
within the temperature band recommended, thus 
defining the performance of the container in the 
environment proposed in Test 2. 
Figure 5 shows the temperature maintenance 
time as a result of the position of each thermopair 
in the container. 
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Figure 5. Temperature maintenance time of the 
vaccine x position of each thermopair in the 
container 
 
RESULTS OF THE EXPERIMENTAL TESTS 
– TEST 3 
 
The mean temperature profile obtained 
remained for a long time below what was expected, 
within the band of tolerance indicated by θ maximum 
and θ minimum. 
 
The vaccine’s conservation time obtained 
during the experiments, at the interval 2 to 8º C, 
was of approximately 2 hours, that is, 0.250 of the 
desired time. 
In the environment proposed, Test 3, the 
vaccine’s conservation times were too short in 
relation to the desired time, due to the direct 
incidence of sunlight, which caused the 
immunobiologicals to heat slightly; as indicated in  
Figures 6 and 7, respectively. 
Table 6 shows the mean values of θ obtained in 
positions A, B, C and D. 
 
TEST 3 – θ Values 
 δ = t / t * Mean Median Mode 
Standard 
Deviation 
0,00 1,00 1,01 1,00 0,01 
0,06 0,97 0,98 0,98 0,01 
0,13 0,95 0,97 0,97 0,01 
0,19 0,93 0,95 0,91 0,02 
0,25 0,93 0,96 0,92 0,02 
 
Table 6 - θ mean values in positions A, B, C and D 
– Test 3 
0.00
0.50
1.00
1.50
0.00 0.50 1.00 1.50 2.00
  δ = t / t *
  
θ
 =
 (
 T
 –
 T
 r
o
o
m
 )
 /
 (
 T
 v
 –
 T
 r
o
o
m
 )
General Mean
Desirable time
Time obtained
θ maximum
θ minimum
 
Figure 6. Mean temperature profile in positions A, 
B, C and D – Test 3 
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 Figure 7. Time of maintenance of the temperature 
of the vaccine x Position of each thermopair inside 
the container. 
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COMPARATIVE ANALYSES BETWEEN 
TESTS 1 AND 2  
 
In this section we compared the mean 
temperature and time obtained from the monitoring 
of the vaccines in Tests 1 and 2, for which the 
performance of the container was satisfactory. The 
purpose of this analysis was to establish a practical 
and dependable parameter of the mean time for the 
use of the container, adequate to the temperature 
band of conservation of the vaccine and desirable 
time for the maintenance of the dependability of the 
quality of the immunobiologicals. 
The Fig. 8 indicates the mean temperature profile 
obtained in Tests 1 and 2 with minimum 
conservation times of 17 and 17.5 hours, 
respectively, which is 9 and 9.5 hours in excess of 
the expected time. 
 
Table 8 – θ mean values in the positions A, B, C 
and D - Tests 1  and  2. 
 TESTS 1 and 2 – θ Values 
δ = t / t * Test 1 Test 2 Mean 
Standard 
Deviation 
0,00 1,00 1,00 1,00 0,00 
0,25 1,14 1,00 1,07 0,10 
0,50 1,14 0,99 1,07 0,11 
0,75 1,14 0,99 1,07 0,11 
1,00 1,14 1,00 1,07 0,10 
1,25 1,15 1,02 1,09 0,09 
1,50 1,15 1,03 1,09 0,08 
1,75 1,15 1,04 1,10 0,08 
2,00 1,15 1,03 1,09 0,08 
2,13 1,14 1,02 1,08 0,08 
 
 
Figure 8. Mean temperature Profile 
                Tests 1 and 2. 
 
Concluding that the proposed container had a very 
good response in the environments represented by 
Tests 1 and 2, they can be used with a very high 
rate of dependability and performance in either 
environment. 
 
 
CONCLUSIONS 
 
The purpose of this study was to develop a 
container to be used in the transportation and 
conservation of immunobiologicals, for a minimum 
8 hours in a temperature between 2 and 8 º C. 
The differential between the designed container 
and the existing ones lays the position the vaccines 
are enclosure in niches, which allows easy handling 
and provides individual thermal insulation.  
 After the container was developed, tests were 
run considering the three environments proposed: 
Test 1 (in a closed room without refrigeration or 
incidence of sunlight); Test 2 (in the open air, in the 
shade) and Test 3 (in the open air with incidence of 
sunlight). 
The results obtained led to the conclusion that 
in environments without direct incidence of 
sunlight, besides living up the expectations, the 
container outdid the performance foreseen 
concerning desirable conservation time of the 
immunobiologicals within the temperature band 
desired. However, in places where the container 
was exposed to the sunlight, the conservation times 
were not satisfactory. 
In Test 1, the immunobiological remained at a 
temperature stabilized above the temperature at the 
beginning of the process, but within the 
temperature band desired for 17 hours. 
As for the second environment proposed, (Test 
2), the monitoring process showed that despite the 
stabilization of the temperatures a little above the 
rate of stabilization observed in Test 1, the mean 
time of maintenance of the immunobiologicals 
within the temperature band required was of 17.5 
hours. 
In Test 3, as the time obtained was of 2 hours 
in this environment, heat penetrated mainly through 
the upper side of the container, which was 
continuously exposed to direct sunlight, since this 
side had no thermal walls (barriers). 
The conservation time of the container that 
guarantees the dependability of the 
immunibiologicals is of 17 hours. 
After the conclusion of the project and 
collection of the experimental results, a patent 
report was written and submitted to INPI under the 
provisional registration number 014060000622. 
As suggestions for further studies we indicate: 
Project and study a more effective thermal 
insulation technique with the inclusion of barriers 
(walls) in the upper surface of the container, 
besides a study of a mathematical model capable of 
simulating adverse temperature and dimension 
conditions.  
 
ACKNOWLEDGEMENTS  
 
To Federal University of Minas Gerais – 
UFMG, through FUNDEP (Foundation of Research 
and Development of UFMG).  
Tecnologia/Technology  Soares et al. Container for the Transportation and … 
Engenharia Térmica (Thermal Engineering), Vol. 7 • No 01 • June 2008 • p. 03-09 9
REFERENCES 
 
Albas, A., Nogueira, R. M. B., Fontolan, O. L., 
Albas, K. S. and Neto, H. B., 2001, The effect of 
freezing on immunogenicity of the rabies vaccine 
produced in suckling mouse brain, Revista da 
Sociedade Brasileira de Medicina Tropical, São 
Paulo, Brazil.  
Côrtes, G. and Papaiordanou, P., 2002, 
<http:www.riscobiológico.org.>, Acesso em 7 fev. 
2005, Armazenamento de Imunobiológicos e Rede 
de Frio, São Paulo, Brazil.  
Datapaq Ltd., Tracker System – 1977, Manual 
de Operação. Datapaq Ltd., Cambrige.  
Funasa, 2001; Manual de Rede de Frio, 
Ministério da Saúde, Brasília, Brazil.  
Hoffmeister, T. O., 2001, 
<http:www.fortdodge.com.br>, Acesso em 14 fev. 
2005, Conservação de Vacinas, São Paulo, Brazil.  
Incropera, F. P. and Dewitt, D. P., 1990, 
Fundamentos de Transferência de Calor e Massa, 
Guanabara Koogan, John Wiley & Sons, New 
York, EUA.  
Malinverni, C., 2003, Distribuição de 
Imunobiológicos, Fomento de Educação Sanitária e 
Imunização em Massa contra Doenças 
Transmissíveis, São Paulo, Brazil.  
Rizzo, E., 1990, Photosensitivity and stability 
of  freeze-dried and reconstituted (Biken CAM-70) 
strain measles vaccines, Revista de Saúde Pública, 
Vol. 24. São Paulo, Brazil.  
Sbeghen, C. C., 1998, 
<http:www.medstudents.com.br/content/resumos>, 
Acesso em 20 fev. 2005, Imunizações, 
Conservação, Transporte e Manuseio de Vacinas, 
Termoestabilidade das Vacinas.  
 
 
